U6Z Fundamental Analysis - URANIUM ENERGY CORP

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to U6Z. U6Z was compared to 61 industry peers in the Oil, Gas & Consumable Fuels industry. No worries on liquidiy or solvency for U6Z as it has an excellent financial health rating, but there are worries on the profitability. U6Z is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year U6Z has reported negative net income.

U6Z had a negative operating cash flow in the past year.

U6Z had negative earnings in 4 of the past 5 years.

In the past 5 years U6Z reported 4 times negative operating cash flow.

1.2 Ratios

U6Z has a Return On Assets of -6.64%. This is amonst the worse of the industry: U6Z underperforms 91.80% of its industry peers.

Looking at the Return On Equity, with a value of -7.43%, U6Z is doing worse than 90.16% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-6.64%
ROE	-7.43%
ROIC	N/A

ROA(3y)-0.75%

ROA(5y)-5.39%

ROE(3y)-0.89%

ROE(5y)-7.03%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 36.62%, U6Z is doing worse than 60.66% of the companies in the same industry.

The Profit Margin and Operating Margin are not available for U6Z so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	36.62%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

U6Z does not have a ROIC to compare to the WACC, probably because it is not profitable.

U6Z has more shares outstanding than it did 1 year ago.

U6Z has more shares outstanding than it did 5 years ago.

There is no outstanding debt for U6Z. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 14.82 indicates that U6Z is not in any danger for bankruptcy at the moment.

Looking at the Altman-Z score, with a value of 14.82, U6Z belongs to the top of the industry, outperforming 98.36% of the companies in the same industry.

There is no outstanding debt for U6Z. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	14.82

ROIC/WACCN/A

WACC9.05%

2.3 Liquidity

U6Z has a Current Ratio of 9.44. This indicates that U6Z is financially healthy and has no problem in meeting its short term obligations.

U6Z's Current ratio of 9.44 is amongst the best of the industry. U6Z outperforms 96.72% of its industry peers.

U6Z has a Quick Ratio of 4.39. This indicates that U6Z is financially healthy and has no problem in meeting its short term obligations.

U6Z's Quick ratio of 4.39 is amongst the best of the industry. U6Z outperforms 95.08% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	9.44
Quick Ratio	4.39

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for U6Z have decreased strongly by -300.00% in the last year.

Looking at the last year, U6Z shows a quite strong growth in Revenue. The Revenue has grown by 12.54% in the last year.

EPS 1Y (TTM)-300%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-532.14%

Revenue 1Y (TTM)12.54%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%42787.93%

3.2 Future

The Earnings Per Share is expected to grow by 57.12% on average over the next years. This is a very strong growth

The Revenue is expected to grow by 57.99% on average over the next years. This is a very strong growth

EPS Next Y-38.88%

EPS Next 2Y115.67%

EPS Next 3Y116.02%

EPS Next 5Y57.12%

Revenue Next Year129.43%

Revenue Next 2Y69.88%

Revenue Next 3Y73.7%

Revenue Next 5Y57.99%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

U6Z reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

The Price/Forward Earnings ratio is 58.62, which means the current valuation is very expensive for U6Z.

Compared to the rest of the industry, the Price/Forward Earnings ratio of U6Z indicates a slightly more expensive valuation: U6Z is more expensive than 77.05% of the companies listed in the same industry.

The average S&P500 Price/Forward Earnings ratio is at 22.13. U6Z is valued rather expensively when compared to this.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	58.62

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

U6Z's earnings are expected to grow with 116.02% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y115.67%

EPS Next 3Y116.02%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for U6Z!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

URANIUM ENERGY CORP

FRA:U6Z (6/13/2025, 7:00:00 PM)

5.4

+0 (+0.06%)

Chartmill FA Rating

GICS SectorEnergy

GICS IndustryGroupEnergy

GICS IndustryOil, Gas & Consumable Fuels

Earnings (Last)03-18 2025-03-18

Earnings (Next)06-16 2025-06-16

Inst Owners77.36%

Inst Owner ChangeN/A

Ins Owners1.81%

Ins Owner ChangeN/A

Market Cap2.32B

Analysts80

Price Target9.11 (68.7%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)1

Avg Revenue beat(2)141.88%

Min Revenue beat(2)-1.07%

Max Revenue beat(2)284.82%

Revenue beat(4)1

Avg Revenue beat(4)20.94%

Min Revenue beat(4)-100%

Max Revenue beat(4)284.82%

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-0.58%

PT rev (3m)-11.23%

EPS NQ rev (1m)-1900%

EPS NQ rev (3m)-1900%

EPS NY rev (1m)0%

EPS NY rev (3m)-186.85%

Revenue NQ rev (1m)-100%

Revenue NQ rev (3m)-100%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-32.36%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	58.62
P/S	39.88
P/FCF	N/A
P/OCF	N/A
P/B	3.04
P/tB	14.53
EV/EBITDA	N/A

EPS(TTM)-0.03

EYN/A

EPS(NY)0.09

Fwd EY1.71%

FCF(TTM)-0.1

FCFYN/A

OCF(TTM)-0.09

OCFYN/A

SpS0.14

BVpS1.78

TBVpS0.37

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-6.64%
ROE	-7.43%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	36.62%
FCFM	N/A

ROA(3y)-0.75%

ROA(5y)-5.39%

ROE(3y)-0.89%

ROE(5y)-7.03%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score5

Asset Turnover0.07

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	220.65%
Cap/Sales	5.45%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	9.44
Quick Ratio	4.39
Altman-Z	14.82

F-Score5

WACC9.05%

ROIC/WACCN/A

Cap/Depr(3y)135.76%

Cap/Depr(5y)103.6%

Cap/Sales(3y)511.99%

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-300%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-532.14%

EPS Next Y-38.88%

EPS Next 2Y115.67%

EPS Next 3Y116.02%

EPS Next 5Y57.12%

Revenue 1Y (TTM)12.54%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%42787.93%

Revenue Next Year129.43%

Revenue Next 2Y69.88%

Revenue Next 3Y73.7%

Revenue Next 5Y57.99%

EBIT growth 1Y-117.97%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-137.78%

EBIT Next 3Y83.01%

EBIT Next 5Y48.91%

FCF growth 1Y-390.29%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-347.79%

OCF growth 3YN/A

OCF growth 5YN/A

URANIUM ENERGY CORP (U6Z.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens